Insider transactions

EDGAR

Privia Health Group, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
40 transactions, 899,644 shares
Sum of shares × price per share: 22,241,091.61

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 106

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-01 Filed 2026-09-03Ernest Opella Finley Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)6,3500—6,350Direct (D) No
F1
  • F1 Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will become fully vested on the day immediately preceding the date of Company's 2027 Annual Meeting of Stockholders.
Open filing 0001759655-26-000076 Read from the filing’s XML Dispute this row
2026-07-09 Filed 2026-07-13Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)21,27527.67
588,679.25

Derived: shares × price per share. Exact value 588679.25.

164,853Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000057 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-09Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)60027.57
16,542

Derived: shares × price per share. Exact value 16542.00.

186,128Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.55 to $27.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001858396-26-000016 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-07Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)53,7222
107,444

Derived: shares × price per share. Exact value 107444.

130,373Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-07Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)53,72227.24
1,463,387.28

Derived: shares × price per share. Exact value 1463387.28.

68,188Direct (D) Yes
F1, F3, F4
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.09 to $27.39 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • F4 Reflects the forfeiture of 8,463 unvested restricted stock units granted on May 20, 2026 under the Issuer's 2021 Omnibus Incentive Plan.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-07Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (53,722) — exercise price 2
Disposed (D)53,7220—3,274,622Direct (D) Yes
F1, F5
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • F5 All of the stock options are fully vested and exercisable.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)24,73427.50
680,185

Derived: shares × price per share. Exact value 680185.00.

186,728Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.51 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001858396-26-000014 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)59,0372
118,074

Derived: shares × price per share. Exact value 118074.

135,688Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)59,03727.33
1,613,481.21

Derived: shares × price per share. Exact value 1613481.21.

76,651Direct (D) Yes
F1, F2
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-02 Filed 2026-07-07Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (59,037) — exercise price 2
Disposed (D)59,0370—3,328,344Direct (D) Yes
F1, F5
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • F5 All of the stock options are fully vested and exercisable.
Open filing 0001401958-26-000010 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)82,6752
165,350

Derived: shares × price per share. Exact value 165350.

159,326Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)45,63426.52
1,210,213.68

Derived: shares × price per share. Exact value 1210213.68.

113,692Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)37,04126.93
997,514.13

Derived: shares × price per share. Exact value 997514.13.

76,651Direct (D) Yes
F1, F4
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (82,675) — exercise price 2
Disposed (D)82,6750—3,387,381Direct (D) Yes
F1, F5
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F5 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)52,8232
105,646

Derived: shares × price per share. Exact value 105646.

129,474Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)52,82325.72
1,358,607.56

Derived: shares × price per share. Exact value 1358607.56.

76,651Direct (D) Yes
F1, F2
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (52,823) — exercise price 2
Disposed (D)52,8230—3,470,056Direct (D) Yes
F1, F5
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F5 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000053 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)63,2122
126,424

Derived: shares × price per share. Exact value 126424.

139,863Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)63,21225.33
1,601,159.96

Derived: shares × price per share. Exact value 1601159.96.

76,651Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.14 to $25.67 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (63,212) — exercise price 2
Disposed (D)63,2120—3,522,879Direct (D) Yes
F1, F4
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F4 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)17,1962
34,392

Derived: shares × price per share. Exact value 34392.

228,658Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)17,19625.18
432,995.28

Derived: shares × price per share. Exact value 432995.28.

211,462Direct (D) Yes
F1, F2
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (5,962) — exercise price 2
Disposed (D)5,9620—0Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (1,001) — exercise price 2
Disposed (D)1,0010—0Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (1,336) — exercise price 2
Disposed (D)1,3360—0Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (8,897) — exercise price 2
Disposed (D)8,8970—0Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000046 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)88,1102
176,220

Derived: shares × price per share. Exact value 176220.

164,761Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)88,11025.33
2,231,826.3

Derived: shares × price per share. Exact value 2231826.30.

76,651Direct (D) Yes
F1, F2
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.70 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (88,110) — exercise price 2
Disposed (D)88,1100—3,586,091Direct (D) Yes
F1, F4
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F4 All of the stock options are fully vested and exercisable.
Open filing 0001759655-26-000048 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22KING DAVID P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—50,775Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000037 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22COCOZZA NANCY G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—42,814Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000042 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Ryu Jaewon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—47,110Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000038 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22McCarthy Thomas A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—27,983Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000040 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22SOISTMAN FRANCIS S JR Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—8,463Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000044 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Morris Matthew Shawn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, par value $0.01 per share
Acquired (A)8,4630—76,651Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000039 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22Kimmet Pamela O Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, par value $0.01 per share
Acquired (A)8,4630—34,172Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000041 Read from the filing’s XML Dispute this row
2026-05-20 Filed 2026-05-22BERBERIAN LANCE Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock, $0.01 par value per share
Acquired (A)8,4630—16,131Direct (D) No
F1
  • F1 On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Open filing 0001759655-26-000043 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13Mehrotra Parth Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value per share
Disposed (D)15,64722.64
354,248.08

Derived: shares × price per share. Exact value 354248.08.

434,357Direct (D) Yes
F3
  • F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Open filing 0001759655-26-000030 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-13Mehrotra Parth Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, $0.01 par value per share
Disposed (D)105,43922.55
2,377,649.45

Derived: shares × price per share. Exact value 2377649.45.

450,004Direct (D) Yes
F1, F2
  • F1 Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000030 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-13Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)3,38522.60
76,501

Derived: shares × price per share. Exact value 76501.00.

211,462Direct (D) No
F1
  • F1 The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Open filing 0001858396-26-000011 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)1,0172
2,034

Derived: shares × price per share. Exact value 2034.

69,205Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Open filing 0001759655-26-000020 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Morris Matthew Shawn Director
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)1,01724.96
25,384.32

Derived: shares × price per share. Exact value 25384.32.

68,188Direct (D) Yes
F1, F3
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $24.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open filing 0001759655-26-000020 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (1,017) — exercise price 2
Disposed (D)1,0170—3,674,201Direct (D) Yes
F1, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • F4 All stock options are fully vested and exercisable.
Open filing 0001759655-26-000020 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)1,2062
2,412

Derived: shares × price per share. Exact value 2412.

216,053Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock, par value $0.01 per share
Disposed (D)1,20625
30,150

Derived: shares × price per share. Exact value 30150.

214,847Direct (D) Yes
F1
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (202) — exercise price 2
Disposed (D)2020—1,336Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (52) — exercise price 2
Disposed (D)520—1,001Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (592) — exercise price 2
Disposed (D)5920—8,897Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-04 Filed 2026-05-05Mountcastle David Officer: EVP Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Purchase) — underlying Common Stock, par value $0.01 per share (360) — exercise price 2
Disposed (D)3600—5,962Direct (D) Yes
F1, F3
  • F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • F3 All of the stock options are fully vested and exercisable.
Open filing 0001858396-26-000009 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-05Morris Matthew Shawn Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock, par value $0.01 per share
Acquired (A)17,0962
34,192

Derived: shares × price per share. Exact value 34192.

85,284Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Open filing 0001759655-26-000020 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
BERBERIAN LANCE DirectorCommon Stock, $0.01 par value per share 16,131D As of 2026-05-20 Open filing 4
COCOZZA NANCY G DirectorCommon Stock, $0.01 par value per share 42,814D As of 2026-05-20 Open filing 4
Ernest Opella Finley DirectorCommon Stock, $0.01 par value per share 6,350D As of 2026-09-01 Open filing 4
Fargis Edward C Officer: EVP General CounselCommon Stock, $0.01 par value per share 111,979D As of 2026-03-10 Open filing 4
KING DAVID P DirectorCommon Stock, $0.01 par value per share 50,775D As of 2026-05-20 Open filing 4
Kimmet Pamela O DirectorCommon Stock, par value $0.01 per share 34,172D As of 2026-05-20 Open filing 4
Maryland Patricia Anne DirectorCommon Stock, $0.01 par value per share 42,312D As of 2025-05-21 Open filing 4
McCarthy Thomas A DirectorCommon Stock, $0.01 par value per share 41,487I By TrustAs of 2026-05-22 Open filing 4
McCarthy Thomas A DirectorCommon Stock, $0.01 par value per share 27,983D As of 2026-05-20 Open filing 4
Mehrotra Parth Director · Officer: Chief Executive OfficerCommon Stock, $0.01 par value per share 434,357D As of 2026-05-12 Open filing 4
Morris Matthew Shawn DirectorStock Option (Right to Purchase) Derivative security · underlying Common Stock, par value $0.01 per share3,274,622D As of 2026-07-06 Open filing 4
Morris Matthew Shawn DirectorCommon Stock, par value $0.01 per share 12,487I By Emerald Family, LLCAs of 2026-07-07 Open filing 4
Morris Matthew Shawn DirectorCommon Stock, par value $0.01 per share 11,998I By TrustAs of 2026-07-07 Open filing 4
Morris Matthew Shawn DirectorCommon Stock, par value $0.01 per share 68,188D As of 2026-07-06 Open filing 4
Mountcastle David Officer: EVP Chief Financial OfficerStock Option (Right to Purchase) Derivative security · underlying Common Stock, par value $0.01 per share0D As of 2026-06-26 Open filing 4
Mountcastle David Officer: EVP Chief Financial OfficerCommon Stock, $0.01 par value per share 8,695I By spouseAs of 2026-07-13 Open filing 4
Mountcastle David Officer: EVP Chief Financial OfficerCommon Stock, par value $0.01 per share 164,853D As of 2026-07-09 Open filing 4
Ryu Jaewon DirectorCommon Stock, $0.01 par value per share 47,110D As of 2026-05-20 Open filing 4
SOISTMAN FRANCIS S JR DirectorCommon Stock, $0.01 par value per share 8,463D As of 2026-05-20 Open filing 4
WICHMANN DAVID S DirectorCommon Stock, par value $0.01 per share 1,315,340I See FootnoteAs of 2025-05-23 Open filing 4
WICHMANN DAVID S DirectorCommon Stock, par value $0.01 per share 25,709D As of 2025-05-21 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 298

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager22,651,844 SH446,014,815 dollarsHigher by 1,249,427 Prior quarter: 21,402,417Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Durable Capital Partners LP Partly reported under another manager11,970,968 SH235,708,360 dollarsHigher by 335,020 Prior quarter: 11,635,948Open filing 0001798849-26-000012 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager6,830,627 SH134,495,036 dollarsLower by 6,017,810 Prior quarter: 12,848,437Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 6,794,248 SH133,778,743 dollarsHigher by 221,864 Prior quarter: 6,572,384Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Rubicon Founders LLC 6,472,513 SH127,443,781 dollarsHigher by 501,434 Prior quarter: 5,971,079Open filing 0002032489-26-000020 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 5,542,666 SH109,135,094 dollarsHigher by 385,946 Prior quarter: 5,156,720Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager5,145,089 SH101,306,802 dollarsHigher by 239,300 Prior quarter: 4,905,789Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Van Berkom Associates Inc. 3,685,410 SH72,566 dollarsLower by 26,213 Prior quarter: 3,711,623Open filing 0001524408-26-000016 Filed 2026-11-04 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager3,519,371 SH69,296,414 dollarsHigher by 1,389,082 Prior quarter: 2,130,289Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager3,203,089 SH63,081,459 dollarsHigher by 72,616 Prior quarter: 3,130,473Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
RIVERBRIDGE PARTNERS LLC 2,895,288 SH57,008,213 dollarsLower by 103,309 Prior quarter: 2,998,597Open filing 0001112325-26-000007 Filed 2026-11-05 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager2,780,710 SH54,752,182 dollarsLower by 111,826 Prior quarter: 2,892,536Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager2,626,685 SH51,718,626 dollarsHigher by 74,824 Prior quarter: 2,551,861Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager2,472,669 SH48,686,852 dollarsLower by 115,209 Prior quarter: 2,587,878Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row
Point72 Asset Management, L.P. 2,044,076 SH40,247,856 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
LOOMIS SAYLES CO L P Partly reported under another manager2,035,244 SH40,073,955 dollarsHigher by 1,020,458 Prior quarter: 1,014,786Open filing 0000312348-26-000039 Filed 2026-11-12 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager2,013,979 SH39,655,247 dollarsHigher by 65,958 Prior quarter: 1,948,021Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager2,005,402 SH39,486,364 dollarsHigher by 703,383 Prior quarter: 1,302,019Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
BlackBarn Capital Partners LP Partly reported under another manager1,870,000 SH48,115,100 dollarsHigher by 285,000 Prior quarter: 1,585,000Open filing 0002010204-26-000008 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager1,802,783 SH35,496,797 dollarsHigher by 337,638 Prior quarter: 1,465,145Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 1,739,427 SH34,249,318 dollarsHigher by 686,156 Prior quarter: 1,053,271Open filing 0001193125-26-422223 Filed 2026-10-15 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager1,592,114 SH31,348,724 dollarsHigher by 159,997 Prior quarter: 1,432,117Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,528,434 SH30,094,866 dollarsHigher by 153,606 Prior quarter: 1,374,828Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager1,262,141 SH24,851,557 dollarsHigher by 8,640 Prior quarter: 1,253,501Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Prosight Management, LP 1,049,752 SH20,669,617 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002713 Filed 2026-11-13 Dispute this row
Qube Research Technologies Ltd 918,610 SH18,087,431 dollarsHigher by 70,456 Prior quarter: 848,154Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager917,285 SH18,061,368 dollarsLower by 88,645 Prior quarter: 1,005,930Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager899,573 SH20,150,435 dollarsLower by 329,043 Prior quarter: 1,228,616Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 899,005 SH17,701,408 dollarsHigher by 52,321 Prior quarter: 846,684Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
ROYCE ASSOCIATES LP 745,948 SH14,687,716 dollarsLower by 79,223 Prior quarter: 825,171Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row
EVENTIDE ASSET MANAGEMENT, LLC 737,694 SH14,525,195 dollarsUnchanged Prior quarter: 737,694Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row
Woodline Partners LP 663,341 SH13,061,184 dollarsHigher by 57,729 Prior quarter: 605,612Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager613,300 SH12,075,877 dollarsLower by 19,400 Prior quarter: 632,700Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
C WorldWide Group Holding A/S Partly reported under another manager610,000 SH12,011 dollarsUnchanged Prior quarter: 610,000Open filing 0001625244-26-000010 Filed 2026-11-04 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager563,729 SH11,099,824 dollarsHigher by 514,894 Prior quarter: 48,835Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 531,612 SH10,467 dollarsNot in the prior quarter’s filings read Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
Invesco Ltd. Partly reported under another manager514,226 SH10,125,111 dollarsHigher by 64,471 Prior quarter: 449,755Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
ArrowMark Colorado Holdings LLC 486,787 SH9,584,836 dollarsHigher by 224,592 Prior quarter: 262,195Open filing 0001172661-26-005265 Filed 2026-11-16 Dispute this row
ENVESTNET ASSET MANAGEMENT INC 442,490 SH8,712,618 dollarsLower by 102,281 Prior quarter: 544,771Open filing 0001214659-26-014231 Filed 2026-11-16 Dispute this row
FIRST TRUST ADVISORS LP 435,451 SH8,574,030 dollarsHigher by 193,021 Prior quarter: 242,430Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
Public Sector Pension Investment Board 434,449 SH9,384,098 dollarsHigher by 27,551 Prior quarter: 406,898Open filing 0001396318-26-000039 Filed 2026-11-10 Dispute this row
LOS ANGELES CAPITAL MANAGEMENT LLC 401,838 SH7,912,191 dollarsHigher by 320,969 Prior quarter: 80,869Open filing 0001177206-26-000010 Filed 2026-11-12 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 395,850 SH7,794,287 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager387,744 SH7,634,679 dollarsHigher by 188,981 Prior quarter: 198,763Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
PEREGRINE CAPITAL MANAGEMENT LLC 386,969 SH7,619,420 dollarsHigher by 26,762 Prior quarter: 360,207Open filing 0000764529-26-000008 Filed 2026-11-09 Dispute this row
FRONTIER CAPITAL MANAGEMENT CO LLC 383,108 SH7,543,397 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005367 Filed 2026-11-16 Dispute this row
Edgestream Partners, L.P. Partly reported under another manager367,720 SH7,240,407 dollarsNot in the prior quarter’s filings read Open filing 0001535061-26-000005 Filed 2026-11-10 Dispute this row
Clearbridge Investments, LLC 355,998 SH7,009,601 dollarsLower by 3,152 Prior quarter: 359,150Open filing 0001348883-26-000026 Filed 2026-11-12 Dispute this row
MILLENNIUM MANAGEMENT LLC 348,314 SH6,858,303 dollarsHigher by 79,990 Prior quarter: 268,324Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Caisse de depot et placement du Quebec 326,424 SH6,427,289 dollarsUnchanged Prior quarter: 326,424Open filing 0001140361-26-043880 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 1,374,828 SH
  • Freestone Grove Partners LP 685,489 SH
  • Weiss Asset Management LP 253,964 SH
  • Campbell CO Investment Adviser LLC 92,153 SH
  • Jump Financial, LLC 84,012 SH
  • JANE STREET GROUP, LLC 73,400 SH
  • GSA CAPITAL PARTNERS LLP 65,048 SH
  • TUDOR INVESTMENT CORP ET AL 62,026 SH
  • VARCOV Co. 58,732 SH
  • Jupiter Topco LLC 44,085 SH
  • BRADLEY FOSTER SARGENT INC/CT 37,862 SH
  • SG Americas Securities, LLC 36,831 SH
  • ALLSTATE CORP 36,110 SH
  • EXCHANGE TRADED CONCEPTS, LLC 33,708 SH
  • Alyeska Investment Group, L.P. 29,797 SH
  • FOX RUN MANAGEMENT, L.L.C. 29,078 SH
  • ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 28,247 SH
  • INTECH INVESTMENT MANAGEMENT LLC 25,029 SH
  • SECTORAL ASSET MANAGEMENT INC 24,136 SH
  • ZACKS INVESTMENT MANAGEMENT 22,217 SH
  • Brevan Howard Capital Management LP 19,378 SH
  • BLAIR WILLIAM CO/IL 18,477 SH
  • Jain Global LLC 17,734 SH
  • MML INVESTORS SERVICES, LLC 17,461 SH
  • IEQ CAPITAL, LLC 16,810 SH
  • ALPINE WOODS CAPITAL INVESTORS, LLC 15,303 SH
  • PARK AVENUE SECURITIES LLC 13,227 SH
  • HighTower Advisors, LLC 12,697 SH
  • OCCUDO QUANTITATIVE STRATEGIES LP 12,140 SH
  • BAILARD, INC. 10,700 SH
  • Sanctuary Advisors, LLC 9,045 SH
  • Quadrature Capital Ltd 9,033 SH
  • DRW Securities, LLC 8,669 SH
  • Marex Group Ltd 7,982 SH
  • Integrated Wealth Concepts LLC 2,866 SH
  • Park Place Capital Corp 1,617 SH
  • SMA Capital LLC 1,074 SH
  • Optiver Holding B.V. 1,023 SH
  • Colonial Trust Co / SC 717 SH
  • J.Safra Asset Management Corp 693 SH
  • Neo Ivy Capital Management 624 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 582 SH
  • Cornerstone Planning Group LLC 230 SH
  • Plante Moran Financial Advisors, LLC 173 SH
  • Rossby Financial, LCC 155 SH
  • High Note Wealth, LLC 73 SH
  • Caitong International Asset Management Co., Ltd 28 SH
  • Rialto Wealth Management, LLC 22 SH
  • Ankerstar Wealth, LLC 14 SH
  • Larson Financial Group LLC 13 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 21.39% and 101.32% of shares outstanding.

Quarter ending 2026-09-30, against 127,768,286 shares on the cover dated 2026-10-30.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 29227,327,933129,450,0648,935
2026-06-30 30226,679,165124,882,2759,178
2026-03-31 29133,328,399124,891,8899,173
2025-12-31 27427,909,272120,833,4269,222
2025-09-30 25926,998,876119,909,4248,469
2025-06-30 28226,784,742117,878,4358,516
2025-03-31 25023,568,744120,845,2668,518
2024-12-31 23325,115,631120,206,2158,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock5.096,513,39309/30/2026 Filed 2026-10-30SCHEDULE 13GOpen filing 0002100119-26-001655 Dispute this row
FMR LLC COMMON STOCK5.06,385,120.5009/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 5Open filing 0000315066-26-002339 Dispute this row
Abigail P. Johnson COMMON STOCK5.06,385,120.5009/30/2026 Filed 2026-10-07SCHEDULE 13G/AAmendment 5Open filing 0000315066-26-002339 Dispute this row
Puma Growth Holdings, LLC Common Stock5.076,472,513.0009/01/2026 Filed 2026-09-08SCHEDULE 13DOpen filing 0000950103-26-013658 Dispute this row
Rubicon Founders OP GP, LP Common Stock5.076,472,513.0009/01/2026 Filed 2026-09-08SCHEDULE 13DOpen filing 0000950103-26-013658 Dispute this row
Rubicon Founders OP GP 2 LLC Common Stock5.076,472,513.0009/01/2026 Filed 2026-09-08SCHEDULE 13DOpen filing 0000950103-26-013658 Dispute this row
Rubicon Founders LLC Common Stock5.076,472,513.0009/01/2026 Filed 2026-09-08SCHEDULE 13DOpen filing 0000950103-26-013658 Dispute this row
Adam Boehler Common Stock5.076,472,513.0009/01/2026 Filed 2026-09-08SCHEDULE 13DOpen filing 0000950103-26-013658 Dispute this row
BlackRock, Inc. Common Stock14.217,929,93706/30/2026 Filed 2026-07-29SCHEDULE 13G/AAmendment 3Open filing 0002012383-26-002862 Dispute this row
Vanguard Portfolio Management Common Stock5.166,382,68503/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100121-26-000595 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 2Open filing 0000102909-26-002064 Dispute this row
Puma Growth Holdings, LLC Common Stock4.75,773,522.0010/20/2025 Filed 2025-10-24SCHEDULE 13G/AAmendment 1Open filing 0000950103-25-013624 Dispute this row
Rubicon Founders OP GP, LP Common Stock4.75,773,522.0010/20/2025 Filed 2025-10-24SCHEDULE 13G/AAmendment 1Open filing 0000950103-25-013624 Dispute this row
Rubicon Founders OP GP 2 LLC Common Stock4.75,773,522.0010/20/2025 Filed 2025-10-24SCHEDULE 13G/AAmendment 1Open filing 0000950103-25-013624 Dispute this row
Rubicon Founders LLC Common Stock4.75,773,522.0010/20/2025 Filed 2025-10-24SCHEDULE 13G/AAmendment 1Open filing 0000950103-25-013624 Dispute this row
Boehler Adam Common Stock4.75,773,522.0010/20/2025 Filed 2025-10-24SCHEDULE 13G/AAmendment 1Open filing 0000950103-25-013624 Dispute this row
FMR LLC COMMON STOCK10.112,364,530.7609/30/2025 Filed 2025-11-05SCHEDULE 13G/AAmendment 4Open filing 0000315066-25-002805 Dispute this row
Abigail P. Johnson COMMON STOCK10.112,364,530.7609/30/2025 Filed 2025-11-05SCHEDULE 13G/AAmendment 4Open filing 0000315066-25-002805 Dispute this row
Puma Growth Holdings, LLC Common Stock5.146,278,522.0008/07/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000950103-25-010165 Dispute this row
Rubicon Founders OP GP, LP Common Stock5.146,278,522.0008/07/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000950103-25-010165 Dispute this row
Rubicon Founders OP GP 2 LLC Common Stock5.146,278,522.0008/07/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000950103-25-010165 Dispute this row
Rubicon Founders LLC Common Stock5.146,278,522.0008/07/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000950103-25-010165 Dispute this row
Adam Boehler Common Stock5.146,278,522.0008/07/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000950103-25-010165 Dispute this row
FMR LLC COMMON STOCK11.413,850,834.0006/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 3Open filing 0000315066-25-002081 Dispute this row
Abigail P. Johnson COMMON STOCK11.413,850,834.0006/30/2025 Filed 2025-08-06SCHEDULE 13G/AAmendment 3Open filing 0000315066-25-002081 Dispute this row
Durable Capital Partners LP Common Stock, $0.01 par value per share9.311,109,588— Filed 2024-11-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001839882-24-039307 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Privia Health Group Inc10.0011,933,031— Filed 2024-07-10SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-24-078887 Dispute this row
The Vanguard Group - 23-1945930 Name of issuer: Privia Health Group Inc9.5511,278,334— Filed 2024-02-13SC 13GRead from the cover page textOpen filing 0001104659-24-021751 Dispute this row
BlackRock, Inc. Common Stock14.517,124,181— Filed 2024-01-23SC 13G/AAmendment 1Read from the cover page textOpen filing 0001086364-24-001440 Dispute this row
BlackRock, Inc. Common Stock12.113,938,867— Filed 2023-07-07SC 13GRead from the cover page textOpen filing 0001306550-23-009499 Dispute this row
Durable Capital Partners LP Common Stock, $0.01 par value per share7.99,090,909— Filed 2023-05-15SC 13GRead from the cover page textOpen filing 0001387131-23-006560 Dispute this row
William M Sullivan Common Stock, $.01 par value5.15,860,117— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001193125-23-038462 Dispute this row
Brighton Family, LLC Common Stock, $.01 par value5.15,845,083— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0001193125-23-038462 Dispute this row
THE GOLDMAN SACHS GROUP, INC. Common Stock, par value $0.01 per share21.724,824,660— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
GOLDMAN SACHS & CO. LLC Common Stock, par value $0.01 per share21.724,824,660— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
MBD 2013, L.P. Common Stock, par value $0.01 per share0.6679,526— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
BROAD STREET PRINCIPAL INVESTMENTS, L.L.C. Common Stock, par value $0.01 per share18.621,191,626— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
BRIDGE STREET 2013 L.P. Common Stock, par value $0.01 per share1.92,139,463— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
BRIDGE STREET 2013 OFFSHORE, L.P. Common Stock, par value $0.01 per share0.4488,744— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C. Common Stock, par value $0.01 per share2.32,628,387— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
MBD 2013 HOLDINGS, L.P. Common Stock, par value $0.01 per share0.9999,460— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
MBD 2013 OFFSHORE, L.P. Common Stock, par value $0.01 per share0.3319,934— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
MBD ADVISORS, L.L.C. Common Stock, par value $0.01 per share0.9999,460— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
BRIDGE STREET 2013 HOLDINGS, L.P. Common Stock, par value $0.01 per share2.32,628,387— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0000769993-23-000272 Dispute this row
Pamplona Capital Partners III, L.P. Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row
Pamplona Equity Advisors III Ltd. Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row
Pamplona Private Equity Carryco III, L.P. Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row
Pamplona Equity Carryco Advisors III, Ltd. Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row
Pamplona PE Investments II, Ltd. Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row
Pamplona PE Investments Malta Limited Common Stock, $0.01 par value per share15.517,741,723— Filed 2023-02-14SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-23-004901 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015258,595
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to Privia Health Group, Inc.